Brent Saunders currently serves as the CEO and Chairman of the Board at Bausch + Lomb, a position he resumed in 2023 after previously holding the role from 2010 to 2013. Saunders is widely recognized in the healthcare and pharmaceutical industries for his extensive experience in leadership and mergers and acquisitions. Throughout his career, he has led transformative deals, such as Allergan’s $63 billion acquisition by AbbVie in 2020, and the merger of Forest Laboratories with Actavis. His expertise in business growth and restructuring has made him a central figure in major transactions across the sector.